Volume 86 Issue 22 | p. 21 | Concentrates
Issue Date: June 2, 2008

Lonza Buys Cell Technology Firm

Department: Business

Lonza has acquired Amaxa, a leader in gene-transfer technology, for an undisclosed sum. The Cologne, Germany-based firm manufactures systems that enable transfer of nucleic acids such as DNA and RNA into cells. Lonza says Amaxa will triple the size of its cell-related R&D operations based in Walkersville, Md. Amaxa's transfer technology is seen as complementary to Lonza's current activity, which is centered on primary cell production.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment